Board of Directors
At Piton Therapeutics, our Board of Directors brings together a distinguished group of leaders with deep expertise across biotechnology, drug development, venture capital, and company building. Their strategic guidance and commitment to innovation help shape our vision, steer our mission, and ensure we stay focused on delivering transformative therapeutics for patients with unmet clinical needs. With decades of combined experience, our board plays a critical role in advancing Piton’s growth and impact in precision medicine.
Dong Kong, Ph.D.
Founder
Chairman of the Board
Director
Michael Hadjisavas, Ph.D.
Director
Nigel J. B. MacClancy
Chief Business Officer
/Acting CEO
Director
Baiteng Zhao, Ph.D.
Director
Bing Feng, MS
Director
Learn about Piton’s AI-powered platform
At Piton Therapeutics, we are revolutionizing precision medicine through our state-of-the-art AI-powered platform, unlocking novel small-molecule therapeutics that target the gut-brain axis with unparalleled specificity.